The Indiana Alzheimer's Disease Research Center is committed to supporting the National Alzheimer’s Project Act (NAPA), an initiative to lead research to prevent and effectively treat Alzheimer’s disease by 2025.
Advanced Technology and Collaboration
Through the Indiana Alzheimer's Disease Research Center and related research facilities and clinical care service centers, Indiana University School of Medicine is working to end the suffering of this disease no matter how long it takes. The school's robust training programs and accomplished faculty are developing new researchers specifically trained to discover innovative approaches to improve understanding, diagnosis and treatment of Alzheimer’s disease and other dementias.
Resources available to researchers at the center include healthy and affected participants and donations from deceased individuals for studies. Specifically, the center has biological specimens, including DNA, RNA, plasma, serum, CSF and PBMC; brain tissue and other post-mortem specimens from individuals affected by Alzheimer’s disease characterized neuropathologically, radiologic images and data extracted from processing of these images; and data acquired from Indiana Alzheimer's Disease Research Center subjects, including demographic, psychosocial, psychiatric, neurological, neuropsychological, neuroradiological, biochemical, genetic and neuropathological information.
Fellowships and Open Positions
Fellowships and NIA-funded pilot projects are available from investigators who work for the Indiana Alzheimer’s Disease Research Center.
The Indiana Alzheimer's Disease Research Center is looking for adults 65 and older with mild to moderate memory difficulties for brain-imaging studies of memory at IU School of Medicine.
“Even with new technologies such as brain imaging and biomarkers, many of the major advances in dementia research have come from analyses of brain tissue. Brain donation is an incredibly important gift to future generations that will help researchers find a cure for the diseases causing dementia.”
—Andrew Saykin, PsyD, Director, Indiana Alzheimer's Disease Research Center